dc.contributor.author | Devereux, Graham | |
dc.contributor.author | Cotton, Seonaidh | |
dc.contributor.author | Barnes, Peter | |
dc.contributor.author | Briggs, Andrew | |
dc.contributor.author | Burns, Graham | |
dc.contributor.author | Chaudhuri, Rekha | |
dc.contributor.author | Chrystyn, Henry | |
dc.contributor.author | Davies, Lisa | |
dc.contributor.author | De Soyza, Anthony | |
dc.contributor.author | Fielding, Shona | |
dc.contributor.author | Gompertz, Simon | |
dc.contributor.author | Haughney, John Andrew Francis | |
dc.contributor.author | Lee, Amanda J | |
dc.contributor.author | McCormack, Kirsty | |
dc.contributor.author | McPherson, Gladys | |
dc.contributor.author | Morice, Alyn | |
dc.contributor.author | Norrie, John | |
dc.contributor.author | Sullivan, Anita | |
dc.contributor.author | Wilson, Andrew | |
dc.contributor.author | Price, David | |
dc.date.accessioned | 2015-07-27T15:20:13Z | |
dc.date.available | 2015-07-27T15:20:13Z | |
dc.date.issued | 2015-06-10 | |
dc.identifier | 53838386 | |
dc.identifier | 2809d7d3-d000-4461-a68a-3b8965bc2be0 | |
dc.identifier | 26058585 | |
dc.identifier | 84931273439 | |
dc.identifier.citation | Devereux , G , Cotton , S , Barnes , P , Briggs , A , Burns , G , Chaudhuri , R , Chrystyn , H , Davies , L , De Soyza , A , Fielding , S , Gompertz , S , Haughney , J A F , Lee , A J , McCormack , K , McPherson , G , Morice , A , Norrie , J , Sullivan , A , Wilson , A & Price , D 2015 , ' Use of low-dose oral theophylline as an adjunct to inhaled corticosteroids in preventing exacerbations of chronic obstructive pulmonary disease : study protocol for a randomised controlled trial ' , Trials , vol. 16 , 267 . https://doi.org/10.1186/s13063-015-0782-2 | en |
dc.identifier.issn | 1745-6215 | |
dc.identifier.uri | http://hdl.handle.net/2164/4707 | |
dc.description | Acknowledgements This project is funded by the National Institute for Health Research Health Technology Assessment Programme (project number 11/58/15). The Uniphyllin MR tablets have been provided gratis by Napp Pharmaceuticals Limited. As a courtesy, Napp Pharmaceuticals Limited will be provided with a copy of any manuscript prior to submission. We would like to acknowledge Nicholas Locantore for providing us with detailed data from the ECLIPSE study. | en |
dc.format.extent | 864755 | |
dc.language.iso | eng | |
dc.relation.ispartof | Trials | en |
dc.subject | COPD | en |
dc.subject | theophylline | en |
dc.subject | inhaled corticosteroids | en |
dc.subject | exacerbation | en |
dc.subject | randomised controlled trial | en |
dc.subject | R Medicine | en |
dc.subject | National Institute for Health Research (NIHR) | en |
dc.subject.lcc | R | en |
dc.title | Use of low-dose oral theophylline as an adjunct to inhaled corticosteroids in preventing exacerbations of chronic obstructive pulmonary disease : study protocol for a randomised controlled trial | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
dc.contributor.institution | University of Aberdeen.Grampian Data Safe Haven (DaSH) | en |
dc.contributor.institution | University of Aberdeen.Health Services Research Unit | en |
dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
dc.contributor.institution | University of Aberdeen.Medical Statistics | en |
dc.description.status | Peer reviewed | en |
dc.identifier.doi | 10.1186/s13063-015-0782-2 | |